ReviewGut microbes2026
Dietary and nutritional strategies for reducing disease risk associated with antibiotic-induced dysbiosis.
Review in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic exposure is a major driver of gut microbiota dysbiosis, and its effects extend beyond transient diversity loss. Persistent alterations in microbial composition and metabolites disrupt intestinal barrier integrity, immune homeostasis, and host metabolic signaling, thereby increasing the risk of chronic diseases. Here, we review the evidence linking antibiotic-induced dysbiosis to disease susceptibility and argue that post-antibiotic recovery should target microbial functions and metabolic network restoration. We also examine a range of nutritional strategies, including dietary adjustments, prebiotics, probiotics, and bioactive nutrients, for their capacity to support beneficial commensal bacteria, restore key microbial metabolites, and enhance the gut ecosystem resilience. However, inter-individual variability in response complicates the development of universal protocols, and limited long-term clinical outcome data make it difficult to determine the clinical value of these interventions. Integrating nutritional science, microbial ecology, and precision medicine will be essential for developing effective personalized interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.